跳至主要内容
临床试验/NCT03362086
NCT03362086Unknown不适用

Establishment of Osteosarcoma Biobank

Peking University People's Hospital0 个研究点目标入组 180 人开始时间: 2018年2月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
180
主要终点
Examine VEGFR-2 and PD-L1 gene expression osteosarcoma

研究概览

简要总结

Osteosarcoma is very rare bone tumor. The investigator set up the biobank to ensure the patients has the chance to participate in future research

详细描述

Samples of blood and other stored material such as slides,frozen tissues and so on .

Questionnaire information, including health history, growth and development, physical activity and family medical history information.

研究设计

研究类型
Observational
观察模型
Family Based
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Proband Inclusion criteria: A diagnosis or suspected diagnosis of osteosarcoma

排除标准

  • non-asian pulmonary metastasis

结局指标

主要结局

Examine VEGFR-2 and PD-L1 gene expression osteosarcoma

时间窗: 3 years

To examine the VEGFR2 and programmed cell death ligand 1 (PD-L1) genes expression of the patients with osteosarcoma.And Analyze their differences.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ren tingting

Lab manager of Musculoskeletal Tumor Center

Peking University People's Hospital

相似试验

The Osteosarcoma Biobank in Peking University... | 临床试验